RBR-35mp4q已完成未知
Study of the role of hydroxychloroquine in immunomodulation and control of hypercoagulability in patients diagnosed with Primary antiphospholipid syndrome
Hemocentro- Universidade Estadual de Campinas0 个研究点开始时间: 2020年1月31日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Intervention
入排标准
- 年龄范围
- 17Y 至 65Y（—）
入选标准
- •Confirmed diagnosis of primary antiphospholipid syndrome with thrombosis; age between 17 and 65 years old
排除标准
- •Diagnosis of active neoplasia; presence of other associated autoimmune diseases; gestational period; antiphospholipid syndrome with isolated obstetric complications
研究者
相似试验
招募中
3 期
Effect of Hydroxychloroquine in patients with repeated implantation failureIRCT2017060634209N1Shahid Beheshti University of Medical Sciences30
进行中（未招募）
不适用
Evaluation of the efficacy of hydroxychloroquine in decreasing immune activation in asymptomatic HIV-infected patients (HCQ-01) - Hydroxychloroquine studyHIV infectionMedDRA version: 9.1Level: LLTClassification code 10020161Term: HIV infectionEUCTR2007-005057-36-GBMedical Research Council
已完成
不适用
HCQ-01 Trial: evaluation of the efficacy of hydroxychloroquine in decreasing immune activation in asymptomatic human immunodeficiency virus (HIV) infected patientsISRCTN30019040Medical Research Council Clinical Trials Unit (MRC CTU) (UK)90
已完成
4 期
A study to compare hydroxychloroquine with aspirin and clopidogrel as an antiplatelet agent.CTRI/2013/03/003485PGIMER20
已完成
不适用
Effect of hydroxychloroquine on recurrent abortion treatmentrecurrent abortion.Spontaneous abortionIRCT2015120910664N2Experimental Medicine Research Centerof Tehran University of Medical Science,Vice chancellor for res60